Prostate Cancer - Results from #26040

Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: A multicenter, phase II, open-label, non-comparative, extension study in Japan - Abstract April 12, 2012

Multiparametric prostate MRI for follow-up monitoring after radiation therapy - Abstract April 12, 2012

A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008 - Abstract April 12, 2012

ASTRO responds to study on growth of IMRT for prostate cancer April 11, 2012

Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients - Abstract April 11, 2012

Late rectal bleeding after 3D-CRT for prostate cancer: Development of a neural-network-based predictive model - Abstract April 11, 2012

Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: A prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study - Abstract April 11, 2012

Two genetic deletions in human genome linked to the development of aggressive prostate cancer April 10, 2012

In vivo versus in vitro individual radiosensitivity analysed in healthy donors and in prostate cancer patients with and without severe side effects after radiotherapy - Abstract April 10, 2012

A new era for castrate resistant prostate cancer: A treatment review and update - Abstract April 10, 2012

A possible link between the pubertal growth of girls and prostate cancer in their sons - Abstract April 10, 2012

Learning image context for segmentation of the prostate in CT-guided radiotherapy - Abstract April 9, 2012

Radical prostatectomy for low-risk prostate cancer following initial active surveillance: Results from a prospective observational study - Abstract April 9, 2012

Hormonal treatment in biochemical recurrence after radical prostatectomy - Abstract April 9, 2012

Does baseline total testosterone improve the yielding of prostate cancer screening? - Abstract April 9, 2012

Systemic inflammation and survival of patients with prostate cancer: Evidence from the Glasgow Inflammation Outcome Study - Abstract April 9, 2012

Prostate-specific antigen screening for prostate cancer in older men in the United States of America - Abstract April 9, 2012

Adverse effects of androgen deprivation therapy in men with prostate cancer: A focus on metabolic and cardiovascular complications - Abstract April 9, 2012

Improved detection of localized prostate cancer using co-registered MRI and (11)C-acetate PET/CT - Abstract April 9, 2012

PSA screening: Determinants of primary-care physician practice patterns - Abstract April 9, 2012

Page 1303 of 1436